GENEVA, Sept. 21 -- REVO-CURES (XIAMEN) PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 2608, No. 26, Hubin North Road, Siming DistrictXiamen, Fujian 361018), 锐康九域(厦门)医药科技有限公司 (中国福建省厦门市思明区湖滨北路26号2608室) filed a patent application (PCT/CN2025/082633) for "FAPAlpha HYDROLYSIS-INDUCED CHARGE REVERSAL LIPOSOME AND COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Mar 14, 2025. With publication no. WO/2025/190397, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent app...